Icona World Med Innovation Forum 17

1.9 by Meeting Play


Jul 7, 2017

Informazioni su World Med Innovation Forum 17

Welcome to the 2017 World Medical Innovation Forum official app!

The 2017 World Medical Innovation Forum will feature the newest technologies to diagnose, treat and manage cardiovascular and cardiometabolic disease.  World Forum keynoters will include the CEOs of Eli Lilly, Boston Scientific, Medtronic, Edwards Life Sciences, Bard, Abiomed, Boehringer Ingelheim, American Heart Association, GE Healthcare, Siemens Healthcare and others, including, dozens of top investors and entrepreneurs and a large number of our Harvard faculty. Moderators have included top journalists from Bloomberg, CBS, CNBC, CNN, Fox and STAT among others. They will be joined by senior health care leaders from the biotech, pharma, and investment communities, and clinicians and investigators from across our hospitals. In addition to examining the cutting-edge issues in the field, the Forum will feature presentations from emerging investigators called First Look, the Discovery Café, and the “Disruptive Dozen”—12 emerging technologies with the potential to revolutionize the selected field over the next decade.

Novità nell'ultima versione 1.9

Last updated on Jul 7, 2017

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Traduzione in caricamento...

Informazioni APP aggiuntive

Ultima versione

Richiedi aggiornamento World Med Innovation Forum 17 1.9

Caricata da

Ahmed Sameeh

È necessario Android

Android 4.0.3+

Mostra Altro

World Med Innovation Forum 17 Screenshot

Commento Loading...
Lingua
Ricerca...
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Abbonato con successo!
Ora sei iscritto ad APKPure.
Iscriviti ad APKPure
Sii il primo ad accedere alla versione anticipata, alle notizie e alle guide dei migliori giochi e app Android.
No grazie
Iscrizione
Successo!
Ora sei iscritto alla nostra newsletter.